Viewing Study NCT06699602


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:00 AM
Study NCT ID: NCT06699602
Status: RECRUITING
Last Update Posted: 2025-10-14
First Post: 2024-11-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module